Edition:
United Kingdom

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

144.00SEK
12:03pm BST
Change (% chg)

-1.00kr (-0.69%)
Prev Close
145.00kr
Open
144.60kr
Day's High
145.00kr
Day's Low
144.00kr
Volume
4,586
Avg. Vol
40,384
52-wk High
169.00kr
52-wk Low
82.00kr

Latest Key Developments (Source: Significant Developments)

Xvivo Perfusion Q2 Net Sales Up At SEK 46.1 Mln
Friday, 20 Jul 2018 

July 20 (Reuters) - Xvivo Perfusion AB ::Q2 NET SALES SEK 46.1 MILLION VERSUS SEK 37.0 MILLION YEAR AGO.Q2 OPERATING INCOME BEFORE DEPRECIATION AND AMORTIZATION (EBITDA) AMOUNTED TO SEK 8.1 (5.7) MILLION.  Full Article

Xvivo Perfusion: Perfadex Plus Approved By The FDA
Monday, 25 Jun 2018 

June 25 (Reuters) - XVIVO PERFUSION AB ::PERFADEX PLUS APPROVED BY THE FDA.  Full Article

Xvivo Q3 EBITDA ex-items at SEK 4.4 million
Friday, 27 Oct 2017 

Oct 27 (Reuters) - XVIVO PERFUSION AB ::Q3 NET SALES SEK ‍32.3​ MILLION VERSUS SEK 31.7 MILLION YEAR AGO.Q3 EBITDA EX-ITEMS SEK ‍4.4​ MILLION VERSUS SEK 5.4 MILLION YEAR AGO.  Full Article

XVIVO Perfusion plans private placement
Friday, 17 Mar 2017 

Xvivio Pwerfusion AB : Announced on Thursday its intention to undertake a private placement of shares . Said intends to offer up to 2,361,408 new shares . The subscription price for the shares in the private placement will be determined in the book building process .Said reason behing private placement is to broaden the shareholder base, said directed share issue means lower costs and faster process.  Full Article

BRIEF-Xvivo Perfusion Q1 Adjusted. EBITDA Sek 7.2 Million

* Q1 ADJUSTED. EBITDA SEK 7.2 MILLION VERSUS SEK 5.0 MILLION YEAR AGO